Yu Cui

1678 Dongfang Road
Dongfang, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

ABCB1 rs2032582 as a potential biomarker for predicting Scutellaria baicalensis Georgi-drug induced liver injury in humans.

ABCB1 rs2032582 as a potential biomarker for predicting Scutellaria baicalensis Georgi-drug induced liver injury in humans.

Journal: Journal of ethnopharmacology

Published: May 19, 2026

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Journal: Frontiers in cellular and infection microbiology

Published: April 25, 2026

Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm.

Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm.

Journal: Journal of integrative medicine

Published: March 02, 2026

Research trends of mitochondrial dysfunction in hepatic fibrosis: a bibliometric analysis.

Research trends of mitochondrial dysfunction in hepatic fibrosis: a bibliometric analysis.

Journal: Frontiers in physiology

Published: December 18, 2025

Randomised, controlled, crossover clinical trial protocol of puerarin for the treatment of metabolic-associated fatty liver disease in China.

Randomised, controlled, crossover clinical trial protocol of puerarin for the treatment of metabolic-associated fatty liver disease in China.

Journal: BMJ open

Published: September 18, 2025

Ferroptosis in liver fibrosis and its potential intervention strategy.

Ferroptosis in liver fibrosis and its potential intervention strategy.

Journal: Cell biology and toxicology

Published: June 14, 2025

Optimized DWI-based virtual MR elastography for diagnosis and therapeutic monitoring of focal liver lesions.

Optimized DWI-based virtual MR elastography for diagnosis and therapeutic monitoring of focal liver lesions.

Journal: European journal of radiology

Published: April 01, 2025

Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways.

Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways.

Journal: Journal of clinical and translational hepatology

Published: January 16, 2025

Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial.

Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial.

Journal: BMJ open

Published: September 14, 2024

Targeting a cardiac abundant and fibroblasts-specific piRNA (CFRPi) to attenuate and reverse cardiac fibrosis in pressure-overloaded heart failure.

Targeting a cardiac abundant and fibroblasts-specific piRNA (CFRPi) to attenuate and reverse cardiac fibrosis in pressure-overloaded heart failure.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: October 10, 2023

Targeting gut microbiota-derived kynurenine to predict and protect the remodeling of the pressure-overloaded young heart.

Targeting gut microbiota-derived kynurenine to predict and protect the remodeling of the pressure-overloaded young heart.

Journal: Science advances

Published: July 14, 2023

LncRNA CFRL aggravates cardiac fibrosis by modulating both miR-3113-5p/CTGF and miR-3473d/FN1 axis.

LncRNA CFRL aggravates cardiac fibrosis by modulating both miR-3113-5p/CTGF and miR-3473d/FN1 axis.

Journal: iScience

Published: March 29, 2023

Showing 1-12 of 12

Last Updated: 09/26/2026